Invictus RG (Singapore)’s Elevance Health ELV Stock Holding History

Invictus RG (Singapore)’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-6,285	Closed	-$880K	–	140
2015 Q3	$880K	Buy	6,285 +2,535	+68%	+$381K	0.82%	4
2015 Q2	$616K	Buy	3,750 +244	+7%	+$39K	0.57%	24
2015 Q1	$541K	Sell	3,506 -668	-16%	-$95.1K	0.51%	41
2014 Q4	$525K	Buy	4,174 +377	+10%	+$46.6K	0.57%	24
2014 Q3	$454K	Buy	3,797 +891	+31%	+$102K	0.57%	22
2014 Q2	$313K	Sell	2,906 -2,664	-48%	-$274K	0.33%	90
2014 Q1	$554K	Sell	5,570 -3,973	-42%	-$359K	0.66%	16
2013 Q4	$882K	Buy	9,543 +4,671	+96%	+$415K	0.6%	15
2013 Q3	$407K	Sell	4,872 -762	-14%	-$65.3K	0.35%	79
2013 Q2	$461K	Buy	+5,634	New	+$422K	0.51%	34

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Invictus RG (Singapore)'s ELV Position: Q4 2015 in Review

Invictus RG (Singapore) sold out of Elevance Health (ELV) in Q4 2015, closing a stake of 6,285 shares — an estimated $880K sold.

Invictus RG (Singapore) first reported a position in ELV in Q2 2013 and held it in 10 quarters. The position peaked at $882K in Q4 2013. 765 funds tracked by Wall St. Rank hold ELV as of Q4 2015.

Invictus RG (Singapore) reported no remaining Elevance Health position as of Q4 2015 after selling out during the quarter.
Invictus RG (Singapore) sold 6,285 Elevance Health shares in Q4 2015, an estimated $880K.
Invictus RG (Singapore) first reported a position in Elevance Health in Q2 2013 and held it in 10 quarters.
Invictus RG (Singapore)'s Elevance Health position peaked at $882K in Q4 2013.
765 funds tracked by Wall St. Rank held Elevance Health as of Q4 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2015.